Zullo Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Sell
5,542
-9
-0.2% -$1.94K 0.48% 50
2026
Q1
$1.21M Sell
5,551
-53
-0.9% -$11.8K 0.46% 50
2025
Q4
$1.28M Sell
5,604
-89
-2% -$20.3K 0.47% 49
2025
Q3
$1.32M Buy
5,693
+121
+2% +$24.6K 0.49% 46
2025
Q2
$1.03M Buy
5,572
+371
+7% +$69K 0.42% 53
2025
Q1
$1.09M Sell
5,201
-13
-0.2% -$2.53K 0.47% 54
2024
Q4
$927K Buy
5,214
+94
+2% +$17.3K 0.37% 61
2024
Q3
$1.01M Sell
5,120
-8
-0.2% -$1.49K 0.42% 57
2024
Q2
$880K Sell
5,128
-63
-1% -$10.4K 0.39% 59
2024
Q1
$945K Buy
5,191
+36
+0.7% +$6.2K 0.44% 58
2023
Q4
$799K Buy
5,155
+91
+2% +$13.3K 0.41% 60
2023
Q3
$755K Buy
5,064
+285
+6% +$41.8K 0.44% 53
2023
Q2
$644K Sell
4,779
-186
-4% -$27.3K 0.37% 61
2023
Q1
$791K Buy
4,965
+156
+3% +$23.9K 0.49% 54
2022
Q4
$777K Buy
4,809
+134
+3% +$20.5K 0.48% 49
2022
Q3
$627K Buy
4,675
+110
+2% +$15.8K 0.4% 55
2022
Q2
$699K Sell
4,565
-127
-3% -$19.4K 0.44% 52
2022
Q1
$761K Buy
4,692
+129
+3% +$18.7K 0.4% 57
2021
Q4
$618K Buy
+4,563
New +$539K 0.32% 68

Other funds holding ABBV

Zullo Investment Group's ABBV Position: Q2 2026 in Review

Zullo Investment Group reduced its AbbVie (ABBV) stake by 0.16% in Q2 2026, selling an estimated $1.94K and leaving 5,542 shares worth $1.39M. The position accounts for 0.48% of the portfolio, ranked #50.

Zullo Investment Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Zullo Investment Group held 5,542 shares of AbbVie worth $1.39M as of Q2 2026.
  • Zullo Investment Group sold 9 AbbVie shares in Q2 2026, an estimated $1.94K.
  • AbbVie made up 0.48% of Zullo Investment Group's portfolio in Q2 2026, its #50 holding.
  • Zullo Investment Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Zullo Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.